“The #1 Penny Stock of 2020” teased by Paradigm… “It holds the $8.18 Trillion Cure to Man’s Biggest Problem”

What's Tim Bohen teasing as having huge potential and a November 7 announcement?

By Travis Johnson, Stock Gumshoe, October 21, 2019

Hard to believe that the major publishers didn’t already have something called The Penny Stock Letter, but this is the first time I’ve seen the title — it’s an entry-level newsletter from Paradigm Press, one of the many publishers in the Baltimore Agoraplex, and they’re promoting it with a big teaser campaign now that hints at “The #1 Penny Stock of 2020” … so that’s our topic for today.

Oddly enough, it looks like you can make money from this subscription by not doing anything at all — they say they’ll refund you $98 on your $49 subscription if you’re not happy in the first six months, so that’s at least a nice, guaranteed 100% return. And even better, that’s 200% if you annualize it!

Will the stock picks they make be as successful as that? Well, probably not, but I have no idea. Let’s look and see what the one they’re teasing might be, shall we?

They’re peddling a special report called “How to Amass a Retirement Fortune from The Biggest Medical Breakthrough in History,” and the lead-in is enough to get anyone excited:

“Backed by Billionaires: Jeff Bezos, Peter Thiel, Venrock Capital, and BlackRock Inc. Reveals…

“THE #1 PENNY STOCK OF 2020
– It holds the $8.18 Trillion Cure to Man’s Biggest Problem
– Shares are dirt cheap at just $6
– And its November 7th announcement could shock the world and start a historic 7-figure market sprint, unlike the world has ever seen…”

The two key words in there? “Could,” and “start.” And I’ll bet the lawyers added them… but this is basically the same spiel that every biotech newsletters uses — there’s a cure for X disease coming, it will be announced in a shocking development in a few weeks, and the gains will be life-changing. I can’t tell you that it never happens that way, but in my experience examining these teaser ads for 12 years now it hasn’t yet happened that way.

Which doesn’t mean the stock won’t be worth considering, of course, just that we should start with a little sobriety and skepticism. So what is the stock?

Let’s check the other clues they drop. The ad says that there’s a secret US Patent that was filed to “end the biggest killer in human history,” with the little patent number blurred out to make us think it’s super-secret. Here’s some more from the pitch:

“In just the last year alone this deadly killer has taken 34.6x times more people than heart disease AND cancer… COMBINED.

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...


“And better yet, this affects the lives of all your friends and loved ones….

“This Tiny $6 Biotech Firm Has Just Discovered The Cure…

“… what we are projecting will be huge…

“10,343% Returns Starting As Soon as November 7th”

And there are some quotes from outside sources that fall into the “other people are also saying it, so it must be real” category:

“I know this sounds nuts, but as Forbes says…

‘The idea behind [this company] sound’s crazy, but it’s backed by dozens of scientific papers.’

“SingularityHub has confirmed the power of this technology, saying…

‘It’s like a 90-year-old human suddenly jumping off the couch and running around the block.’

“Technology & business news, The Hustle, says…

‘Study shows [this tech] could increase the human lifespan by almost 35%.'”

And they dive deeper into those big backers, too:

“Founder of Amazon and the world’s richest man Jeff Bezos has invested $151 million.

“Venrock Capital, started by the Rockefeller family invested upwards of $55 million.

“Billionaire investor and founder of PayPal Peter Thiel is also in.”

What about the company? We get a few more clues:

“PRNewswire says:

‘[this company’s team] has collectively moved more than 90 therapeutic candidates into human clinical trials and developed 13 FDA –approved medicines.'”

And…

“The genius behind this company had one (of his many) biotech ventures be acquired for over $2.1 billion.”

So what’s the stock? Thinkolator sez the stock being teased here is Unity Biotechnology (UBX), and the disease they’re fighting is aging. I grow more sympathetic with the anti-aging researchers each year, of course, so I can understand why aging billionaires and venture capital folks love to throw money at the promise of extending the human lifespan — including Peter Thiel, who has invested in a bunch of anti-aging companies (and, yes, is on board with UBX as an early venture investor, along with Venrock and Bezos and others).

Unity Biotechnology is an interesting story — there’s a good in-depth piece here from Quartz that appeared two years ago, before Unity went public. This is a little excerpt:

“The company’s approach is deceptively simple: clearing the body of senescent cells, which are trapped in a state of purgatory between division and death—they’re still alive, but they’re not making new tissues. Cells in this mode are found throughout the body, and research has shown that they can congregate in areas that start to wear with aging, like the eyes and in joints. A recent paper in Science, coauthored by Unity founders Van Deursen and Judith Campisi of the Buck Institute for Research on Aging, demonstrated that, in mice, senescent cells contribute to atherosclerosis, the buildup of plaque in the arteries.”

Unity went public during a happier market for biotech companies, in mid-2018, and is now trading at about $7 a share (it briefly got over $20 a share a little over a year ago). And yes, they are expecting to announce their next earnings report on November 7, so that date wasn’t just pulled out of the air by the ad copywriter… but they’re not going to announce shocking results or a “cure for aging” on that day.

Earnings reports don’t generally mean anything for clinical-stage biotechs, and Unity is in a fairly quiet period where we’ve seen their Phase 1 results from their first drug, but we’ll probably have to wait quite a while before there’s any more meaningful drug development news. And those first results for their knee osteoarthritis treatment were, at least from my perspective, pretty unimpressive — Phase 1 is mostly designed to make sure a drug is safe enough to try on a broader group of patients, but they also want to see if it is effective… and for many of the indications, the placebo did as well or nearly as well in reducing pain in osteoarthritis sufferers. The press release headline was that “topline results demonstrate a dose-dependent and clinically meaningful impact on pain,” and that they showed enough progress to plan for Phase 2, but it certainly wasn’t a “wow, this is amazing!” result.

The company’s goal is to extend the “health span” of humans, dealing with some diseases and conditions that significantly impact the joy of living like osteoarthritis and macular degeneration, and this first clinical trial is important in that the drug at least seemed safe and well-tolerated. Whether things improve from here, I have no idea — but it will presumably be a while, they just started enrolling for the Phase 2 trial, and they don’t expect to report results until sometime in the second half of 2020 (they’re planning a “parallel” 1b study as well, with multiple doses and a higher dose, don’t know when those results might be available but presumably it’s also at least a 12-week study so it will be sometime next year).

And the next wave of research they do will be in Ophthalmology, where they have identified their first clinical candidate — but they haven’t even filed an IND for that yet (that’s an Investigational New Drug application — basically, sharing their toxicology results and other background info, including stuff about the manufacturing of the compound, outlining the clinical trial protocols they intend to follow, and requesting approval to test the drug in humans)… so we won’t be seeing any actual clinical trial results from those drugs in the next few months, either.

As of June, UBX still has about $125 million in cash to fuel their R&D programs, so they should be OK for a little while — even with a Phase 2 trial underway which should increase their costs, that will probably be enough to get them at least a quarter into 2020 (so far this year they’ve been burning through about $20 million in cash per quarter), though like any early-stage biotech they will probably use any moments of investor optimism to raise more money — and they will almost certainly need to raise funds before they have Phase 2 results from their lead drug next year.

So is Unity Biotechnology a good candidate for you? Only you can answer that, I’m afraid — I don’t like to dabble in early stage biotechs because I can be fairly sure that I’m buying shares from someone who understands the science a lot better than I do, and I don’t see any reason to expect a big “price catalyst” bit of news from Unity anytime in the next few months that might attract the biotech crowd, so this one isn’t for me — but they do have plenty of backers and some interesting-sounding science, so perhaps it will eventually become a big winner. You’ll have to make your call on where you see the probabilities falling for this one, and I hope you’ll share your thoughts with a comment below… thanks for reading!


Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? Log in)

23
Share your thoughts...

avatar
14 Comment threads
9 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
20 Comment authors
jaygumFRANK8MORRISSsenior111chemtechjflynch Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Pam Day
Guest
Pam Day

I THINK ALL I read on pot stocks,results are very similar for joint pain,arthritis,etc….Travis,have you read this too.? Also,alzheimers…just not big on all of these PHARMA drugs and other effects from them..todays world makes me more of a naturalist…and vitamins for health without side effects…your thoughts please..

Add a Topic
4453
gillo
Member
👍70
gillo

Been in this one for a while, and down quite a bit. It’s mostly a play, as Travis mentioned, on the anti aging trend that’s starting to grow pretty substantially as the Boomers get creaky. The general scientific rationale seems reasonable. The people running it and the roster of investors also factored into my decision to purchase a small tranche. If I live long enough maybe I’ll make some profit.

Carbon Bigfoot
Guest
Carbon Bigfoot

We (Silent Generation—transitional) older boomers have found that rescuing a dog and walking them daily solves many issues, including joint issues. MOVE FREE ULTRA with its hyaluronic acid has been a godsend. $30/mo. available from Walmart and I avoided knee surgery. Give it several months to work (varies). 120 Million Americans are OBESE and REALLY FAT. This causing all 31 diseases of civilization. Exercise and push-away from the table, sensible eating, NO BEER or minimizing other carbs works better. Stay away from excess computer, tablet, cell phone and WIFI EMF to avoid triggering autoimmune responses. In conclusion, I object to… Read more »

Vince
Guest
Vince

The real cannabis penny stock at the moment is BOT.asx if the phase 2 result comes out positive then big profit for investors on the cards.

dazza06
Member
👍9
dazza06

BOT is accumulating nicely currently see below;

https://www.asx.com.au/asx/share-price-research/company/BOT

Id put this one on a watch list for now, no urgent need to rush in at the moment..another one to watch down her eon ASX is Elixinol (ASX – EXL), its about to push into the EU and has regressed over the past few months in price so if your a believer in the prospective fortunes that may be made when EU approval is granted then check it out also..

gillo
Member
👍70
gillo

Maybe I should have said “cranky” rather than “creaky” 😉

jbecket
Irregular
👍79

I’m impressed Travis et al of the research you do, thus nullifying to a degree my gullibility.

patches
Irregular
👍43
patches

I second that!

geraldfdavis
Member
👍3
geraldfdavis

There is no cure , no drug can cure disease. All drugs are toxic , drugs mask the symptoms.

Commentor
Guest
Commentor

Yes. So true!!

But society has been brainwashed by BIG pharma to ‘think’ otherwise. Obesity (or the NEW gigantism) in people is from VACCINES! and other viruses that require SUGAR (feeding) to survive. What a spider’s web we live in!!

troywilson15
Member
👍4
troywilson15

Fasting heard of it, It is a very good way to begin turning sickness around in your body maybe I should say turning your health around

BajaPete
Guest
BajaPete

Retuxin (chemotherapy) destroyed about 60% of my stage 4 lymphoma tumor and radiation did the rest. If you ever contract cancer I think you’ll change your mind on drugs or you won’t be around if you don’t.

ziporange
Irregular
👍3
ziporange

Thank you for your testimony…

Same problem with vaccines, people are busy being afraid of drugs that make life easier or even safe others! They just stop vaccinating their children resulting in a outbreak of some pathology.

No problem with naturopathy or homeopathy or any other parallel medecine as long as you are also listening to traditionnal medecine.

FMPOV

jaygum
Member
👍0
jaygum

Not a true statement, geraldfdavis. Some drugs do cure disease, such as antibiotics that kill the pathogenic organism causing the disease.

Brian
Irregular
👍6
Brian

Agora Financial is getting sued YET AGAIN for deceptive business practices. These guys have no morals. If this link does not show, search the Washington Post for “FTC sues Agora Financial.”

practiceshttps://www.washingtonpost.com/business/ftc-sues-to-block-promoters-of-bogus-diabetes-cure/2019/10/24/86227066-f6a3-11e9-b2d2-1f37c9d82dbb_story.html

edw2269
Irregular
👍51
edw2269

October 24, 2019 Unity Biotechnology Announces Upcoming Scientific Presentations about a late-breaking abstract on the recent Phase 1b study of UBX-0101 on November 12 at ACR 2019 Annual Meeting. Just wondering if this will send stock higher, enough to take a small stake in before the presentation?

senior111
Member
👍4
senior111

A Harvard medical resercher, David Sinclaire, has been working on aging for the last couple of decades. He found a naturally occurring compound, NMN which slows and reverses aging cells. So far the mouse experiments have shown great promise. Since NMN is a naturally occurring in our bodies, and plants. His wife, father, and himself have been taking NMN for a long time. NMN improves NAD, a vital natural compound in our bodies that impacts the mitochondria that are the source of energy for the cells. A person experiences aging when the mitochrondial functions are reduces or impaired. In experiments… Read more »

jflynch
Guest
jflynch

Senior 111, I like your post. Yes NAD is very important….heard that before. I’ll have to look into it more as I have been looking for the fountain of youth for along time via researching herbs and new herbal formulations…..however none that had the effects for improving NAD, except for some vitamins which are supposed to do that….which I heard along time ago. Some foreign countries have been doing research as you have said. The US is way behind possible due to the Big Pharma. I will have to research NMN as I haven’t heard about it before. Thank you….and… Read more »

chemtech
Member
👍2
chemtech

An NAD synergizer was just launched by a leader in nutrogenomics in early in October 2019/ NAD supports or fuels the supposed longevity proteins called sirtuins. NAD is increased by 100% in 24 hours after taking the NAD synergizer. The same results can be had if you limit your calorie intake to 700 calories /day for as long as you want to increase your NAD.

senior111
Member
👍4
senior111

Please see my comment on this topic, aging. Also view Youtube videos on NMN and DR. D. Sinclaire. You will be impressed by what NMN has done on experimental mice. Human trials are on the way.

FRANK8MORRISS
Guest

Hello Gum Shoe’s
Marijuana will put big pharma out of business, not because every pill will not be needed anymore. But Big Pharma is used to Billions of $$$, they won’t be able to function without all that income anymore. It will delete so many pharmaceuticals. That it won’t be big Pharma anymore, and they won’t be calling shots in D.C. Yes, it’s all over for “BIG” Pharma, Marijuana with all it can do, they haven’t even scratched the surface yet. So as each day that goes by another pill will no longer be needed.
Thank :-: You
FRANKeightMORRISS